FDLI s IP Throughout the Drug Development Lifecycle

Size: px
Start display at page:

Download "FDLI s IP Throughout the Drug Development Lifecycle"

Transcription

1 FDLI s IP Throughout the Drug Development Lifecycle Post-Marketing IP Protection & Enforcement: View From the Generic Side Janine A. Carlan Arent Fox LLP Topics To Be Discussed Hatch-Waxman Process Orange Book ( OB ) Patent Strategies Paragraph IV ( PIV ) Notice Letter Authorized Generics Mining Data for Patentable Inventions 1

2 Hatch-Waxman Process Timeline: AFF Letter Received from FDA Within 20 Days: File PIV Notice Letter Within 45 Days: Suit by Brand Company - triggers 30-month stay of ANDA approval - calculated from date LAST recipient receives the PIV Notice Letter [21 CFR (f)] - District Court decision - Federal Circuit decision Hatch-Waxman Process (cont d) Goals: - Market entry day exclusivity [21 USC 355(j)(5)(B)(iv)] 2

3 OB Patent Strategies PI-PIV Certifications: Under 21 USC 355(j)(2)(A)(vii): (I) No patent information filed, (II) Patent expired, (III) Wait for patent to expire, or (IV) Patent is invalid or not infringed OB Patent Strategies (cont d) Section viii Statement: An abbreviated application for a new drug [ANDA] shall contain-... (viii) if with respect to the listed drug referred to in clause (i) information was filed under subsection (b) or (c) for a method of use patent which does not claim a use for which the applicant is seeking approval under this subsection, a statement that the method of use patent does not claim such a use. [21 USC 355(j)(2)(A) (emphasis added)] 3

4 OB Patent Strategies (cont d) AstraZeneca Pharm. LP v. Apotex Corp., 669 F.3d 1370 (Fed. Cir. 2012) No viable claim for infringement under 35 USC 271(e)(2) in view of the section viii statement : It shall be an act of infringement to submit--(a) an application... for a drug claimed in a patent or the use of which is claimed in a patent... if the purpose of such submission is to obtain approval under such Act to engage in the commercial manufacture, use, or sale of a drug... claimed in a patent or the use of which is claimed in a patent before the expiration of such patent. [35 USC 271(e)(2)] OB Patent Strategies (cont d) Which patents to challenge? First generation patents Compound (API) patent First medical use Second generation patents Formulation patent (extended release, stabilizer, unique tablet configuration, etc.) Polymorph Second (newly-approved) medical use 4

5 OB Patent Strategies (cont d) Which patents to challenge? First generation patents Compound or first (only?) medical use patents: most difficult to challenge invalidity only, generic must infringe Second generation patents Formulation patent or polymorph non-infringement via design-around invalidity via obvious design choice Second (newly-approved) medical use section viii statement OB Patent Strategies (cont d) With increasing generic competition: Challenges come earlier in product life cycle Challenges frequently occur on NCE-1 date (after 4 th year of FDA approval) Possibility of forfeiture increases 5

6 OB Patent Strategies (cont d) NCE-1 challengers must consider forfeiture provision of FFDCA First ANDA applicant must market within 75 days of: (a) Appellate court decision in ANDA applicant s favor; (b) Settlement finding patent not infringed or invalid; or (c) Patent withdrawal OB Patent Strategies (cont d) Hypothetical: Which patents to challenge? 1 Compound patent (late 2019) 2 Formulation patents (2021 & 2023) NCE-1 date June 1, ½ year rule stay ANDA approval until early 2016 Trial court decision 2016? Fed. Cir. decision late 2017? Forced to challenge compound patent 6

7 OB Patent Strategies (cont d) Choose patent challenges in accordance with long-term business objectives Avoid potential forfeiture situations Seek legal advice on the timeline PIV Notice Letter Requirements for providing notice Statute: 21 USC 355(j)(2)(B) Regulations: 21 CFR & The Applicant shall include in the [ANDA] a statement that the applicant will give notice.... [35 USC 355(j)(2)(B)(i) and (iii)] 7

8 PIV Notice Letter (cont d) Minimum Requirements: (i) state that the ANDA contains bioavailability or bioequivalence data; and (ii) include a detailed statement of the factual and legal basis of the opinion of the applicant that the patent is invalid or will not be infringed. [21 USC 355 (j)(2)(b)(iv)] PIV Notice Letter (cont d) Content Controversies: What is sufficiently detailed? Fewer facts, detail and argument Narrows potential discovery Does not reveal litigation strategy May risk allegation of baseless certification More facts, detail, argument Broadens potential discovery Coextensiveness with litigation strategy closely scrutinized May increase likelihood of settlement 8

9 PIV Notice Letter (cont d) Yamanouchi Pharm. Co., Ltd. v. Danbury Pharmacal, Inc., 231 F.3d 1339 (Fed. Cir. 2000) No prima facie case of invalidity presented Attorney s fees awarded Takeda Chem. Indus., Ltd. v. Mylan Labs., Inc., 549 F.3d 1381 (Fed. Cir. 2008) No reasonable basis to claim patent invalid Notice letters did not match invalidity & unenforceability theories PIV Notice Letter (cont d) Offer of Confidential Access (OCA) ANDA applicant alleges non-infringement as a basis of a PIV certification MUST provide OCA to ANDA to preserve the right to file a Declaratory Judgment Action Not required to provide samples or other supporting documents 9

10 PIV Notice Letter (cont d) Recipients of notice: NDA Holder Listed on FDA website and in Orange Book and Patent Owner(s) Listed on USPTO assignment database Timing PIV Notice Letter (cont d) Newly-filed ANDA No later than 20 days after postmark date on FDA s AFF letter stating the ANDA has been filed [21 USC 355(j)(2)(B)(ii)(I)] Filed = FDA has made a threshold determination that the [ANDA] is sufficiently complete to permit a substantive review. [21 CFR (b)(1)] Existing ANDA At the time a supplement/amendment is submitted [21 USC 355(j)(2)(B)(ii)(II) & 21 CFR (d)] 10

11 PIV Notice Letter (cont d) Timing Controversies: How early? No earlier than postmark date on FDA s AFF letter SB Pharmco Puerto Rico Inc. v. Mutual Pharm. Co. Inc., 552 F.Supp.2d 500 (EDPA 2008) What is at the same time for existing ANDAs? Immediate notice reduces risk that another applicant will obtain exclusivity Purepac Pharm. Co. v. Thompson, 354 F.3d 877 (Fed. Cir. 2004) PIV Notice Letter (cont d) How to send Notice? U.S. Postal Service, registered or certified mail, return receipt requested Use tracking to obtain receipt information as proof of delivery Courier Advance permission required from FDA 11

12 Authorized Generics A brand company s product repackaged and marketed as a generic through a subsidiary or third party Timing: Typically at end of NDA holder s exclusivity Can compete directly against a generic during the 180-day exclusivity Examples: Provigil (modafinil), Geodon (ziprasidone) & Lipitor (atorvastatin) Authorized Generics (cont d) v. Hypothetical revenues in millions 6 months after generic entry in a $500 million product [Glass, Authorized Generics, Nature Reviews 4: (2005)] 12

13 Mining Data for Patentable Inventions Formulation patents Dosage form patents API & formulation method patents Thank You Janine A. Carlan Arent Fox LLP 1050 Connecticut Avenue, NW Washington, DC

Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day

Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research

More information

NJIPLA s 25th Annual Pharmaceutical / Chemical Patent Practice Update First Applicant Generic Exclusivity and Forfeiture Thereof.

NJIPLA s 25th Annual Pharmaceutical / Chemical Patent Practice Update First Applicant Generic Exclusivity and Forfeiture Thereof. NJIPLA s 25th Annual Pharmaceutical / Chemical Patent Practice Update First Applicant Generic Exclusivity and Forfeiture Thereof December 7, 2011 Andrew S. Wasson Frommer Lawrence & HaugLLP Editor, FDALawyersBlog

More information

Overcoming Restriction Requirements On Pharma Patents

Overcoming Restriction Requirements On Pharma Patents Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Overcoming Restriction Requirements On Pharma Patents

More information

Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNIMED PHARMACEUTICALS, LLC, BESINS HEALTHCARE INC., and BESINS

More information

Case 2:12-cv-01941-GMN-GWF Document 1 Filed 11/09/12 Page 1 of 7

Case 2:12-cv-01941-GMN-GWF Document 1 Filed 11/09/12 Page 1 of 7 Case :-cv-0-gmn-gwf Document Filed /0/ Page of GORDON SILVER MOLLY M. REZAC, ESQ. Nevada Bar No. Email: mrezac@gordonsilver.com JUSTIN J. BUSTOS, ESQ. Nevada Bar No. 0 Email: jbustos@gordonsilver.com Suite

More information

Inter Partes Review: Generic Pharma Has Found a Powerful Patent- Busting Weapon David E. De Lorenzi and George W. Johnston,

Inter Partes Review: Generic Pharma Has Found a Powerful Patent- Busting Weapon David E. De Lorenzi and George W. Johnston, Inter Partes Review: Generic Pharma Has Found a Powerful Patent- Busting Weapon David E. De Lorenzi and George W. Johnston, New Jersey Law Journal IP Supplement September 15, 2014 When the Delaware district

More information

First to File and Beyond: Paragraph IV Business Strategies

First to File and Beyond: Paragraph IV Business Strategies First to File and Beyond: Paragraph IV Business Strategies THOMSON REUTERS INTELLECTUAL PROPERTY & SCIENCE GENERICS & API INTELLIGENCE Benjamin Burck Research Analyst and Project Manager Generics & API

More information

V enue can have a dramatic impact on Hatch-

V enue can have a dramatic impact on Hatch- Pharmaceutical Law & Industry Report Reproduced with permission from Pharmaceutical Law & Industry Report, 13 PLIR 372, 03/13/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033)

More information

Warren D.Woessner 612-373-6903 wwoessner@slwk.com. William F. Prout 612-373-6968 wprout@slwk.com

Warren D.Woessner 612-373-6903 wwoessner@slwk.com. William F. Prout 612-373-6968 wprout@slwk.com Warren D.Woessner 612-373-6903 wwoessner@slwk.com William F. Prout 612-373-6968 wprout@slwk.com Schwegman Lundberg Woessner & Kluth 121 S. 8 th Street (1600) Minneapolis, MN 55419 612-373-6900 1 William

More information

Case 8:09-cv-01193-MRP-MLG Document 8 Filed 10/27/2009 Page 1 of 14

Case 8:09-cv-01193-MRP-MLG Document 8 Filed 10/27/2009 Page 1 of 14 Case :0-cv-0-MRP-MLG Document Filed //00 Page of California Street San Francisco, CA -0 0 Gail J. Standish (SBN: gstandish@winston.com Peter E. Perkowski (SBN: pperkowski@winston.com WINSTON & STRAWN LLP

More information

You Know It Is Coming: Preparing for the Paragraph IV Letter

You Know It Is Coming: Preparing for the Paragraph IV Letter You Know It Is Coming: Preparing for the Paragraph IV Letter John Farrell, Fish & Richardson Matt Onaitis, Somaxon William Scarff, Allergan Jonathan Singer, Fish & Richardson Table of Contents Regulatory

More information

Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions. An FTC Staff Study January 2010. Federal Trade Commission ftc.

Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions. An FTC Staff Study January 2010. Federal Trade Commission ftc. Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions An FTC Staff Study January 2010 Federal Trade Commission ftc.gov Summary Brand-name pharmaceutical companies can delay generic competition

More information

Federal Circuit Clears the Way for Large False Patent Marking Fines. by Corina Tanasa January 27, 2010

Federal Circuit Clears the Way for Large False Patent Marking Fines. by Corina Tanasa January 27, 2010 Federal Circuit Clears the Way for Large False Patent Marking Fines by Corina Tanasa January 27, 2010 PATENT MARKING By statute, each patented product must be marked to collect maximum patent damages.

More information

Testimony of. J. Douglas Richards Partner, Cohen Milstein Sellers & Toll, PLLC

Testimony of. J. Douglas Richards Partner, Cohen Milstein Sellers & Toll, PLLC Testimony of J. Douglas Richards Partner, Cohen Milstein Sellers & Toll, PLLC Before the Subcommittee on Intellectual Property, Competition and the Internet of the House Committee on the Judiciary Room

More information

Personal Jurisdiction In Hatch-Waxman Actions In View of Daimler. By: Brian D. Coggio Ron Vogel

Personal Jurisdiction In Hatch-Waxman Actions In View of Daimler. By: Brian D. Coggio Ron Vogel Personal Jurisdiction In Hatch-Waxman Actions In View of Daimler By: Brian D. Coggio Ron Vogel Prior to the Supreme Court s decision in Daimler, 1 concerns over personal jurisdiction in Hatch-Waxman actions

More information

Patent Litigation Strategy: The Impact of the America Invents Act and the New Post-grant Patent Procedures

Patent Litigation Strategy: The Impact of the America Invents Act and the New Post-grant Patent Procedures Patent Litigation Strategy: The Impact of the America Invents Act and the New Post-grant Patent Procedures Eric S. Walters and Colette R. Verkuil, Morrison & Foerster LLP This Article discusses litigation

More information

Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law

Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law By Michael Clancy,* Damien Geradin** and Andrew Lazerow*** In the pharmaceutical

More information

Strengthening (or Weakening) Patent Protection in the United States

Strengthening (or Weakening) Patent Protection in the United States Strengthening (or Weakening) Patent Protection in the United States Licensing Association (Thailand) Patent Strategies for Licensing October 14, 2014 Paul T. Meiklejohn Dorsey & Whitney LLP 1 2 Techniques

More information

Settlement Traps for the Unwary

Settlement Traps for the Unwary Settlement Traps for the Unwary Orange County Bar Association Intellectual Property/Technology Law August 21, 2006 Steve Comer Jae Hong Lee, MD, MPH 2005 Morrison & Foerster LLP All Rights Reserved 3 Cases

More information

Volume IX, Issue 1, Fall 2002 CASE ANALYSIS - IN RE BUSPIRONE PATENT AND ANTITRUST LITIGATION

Volume IX, Issue 1, Fall 2002 CASE ANALYSIS - IN RE BUSPIRONE PATENT AND ANTITRUST LITIGATION Volume IX, Issue 1, Fall 2002 CASE ANALYSIS - IN RE BUSPIRONE PATENT AND ANTITRUST LITIGATION....Tim Meade..Professor Hildreth..Patent Seminar St. John s University School of Law..4/18/02 Background Section

More information

Case: 1:10-cv-01370-BYP Doc #: 48 Filed: 11/12/10 1 of 10. PageID #: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

Case: 1:10-cv-01370-BYP Doc #: 48 Filed: 11/12/10 1 of 10. PageID #: <pageid> UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION Case: 1:10-cv-01370-BYP Doc #: 48 Filed: 11/12/10 1 of 10. PageID #: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION Progressive Casualty Insurance Co., ) CASE NO. 1:10

More information

Legal FAQ: Introduction to Patent Litigation

Legal FAQ: Introduction to Patent Litigation Legal FAQ: Introduction to Patent Litigation by charlene m. morrow and dargaye churnet 1. Who enforces a patent? The U.S. Patent and Trademark Office grants a patent. Contrary to popular belief, a patent

More information

Federal Circuit Review

Federal Circuit Review Federal Circuit Review Infringement Volume One Issue Six March 2009 In This Issue: g Direct and Indirect Infringement g Joint Infringement g Hatch-Waxman Safe Harbor and Research Tools g Infringing Use

More information

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

More information

The Hatch-Waxman Framework Before marketing a new drug in the United States, the federal Food, Drug and Cosmetics Act (FDCA) requires a

The Hatch-Waxman Framework Before marketing a new drug in the United States, the federal Food, Drug and Cosmetics Act (FDCA) requires a REPRINTED WITH PERMISSION FROM: IPL NEWSLETTER, A PUBLICATION OF THE ABA SECTION OF INTELLECTUAL PROPERTY LAW VOL. 23, NO. 4 (SUMMER 2005). ALL RIGHTS RESERVED. THIS INFORMATION OR ANY PORTION THEREOF

More information

Bad Faith: Choice of Law Matters

Bad Faith: Choice of Law Matters Bad Faith: Choice of Law Matters Edwards Angell Palmer & Dodge Insurance and Reinsurance Review - September 2010 Marc S. Voses Choice of law issues cannot be overlooked in insurance bad faith litigation,

More information

Case 1:14-cv-05919-JEI-KMW Document 43 Filed 05/20/15 Page 1 of 2 PageID: 254

Case 1:14-cv-05919-JEI-KMW Document 43 Filed 05/20/15 Page 1 of 2 PageID: 254 Case 1:14-cv-05919-JEI-KMW Document 43 Filed 05/20/15 Page 1 of 2 PageID: 254 LAWRENCE C. HERSH Attorney at Law 17 Sylvan Street, Suite 102B Rutherford, New Jersey 07070 (201) 507-6300 AUSTIN HANSLEY Austin

More information

DOUBLE PATENTING CONSIDERATIONS by Mark Cohen

DOUBLE PATENTING CONSIDERATIONS by Mark Cohen DOUBLE PATENTING CONSIDERATIONS by Mark Cohen The Federal Circuit recently issued an important decision with respect to restriction practice and obviousness double patenting in Pfizer Inc. v. Teva Pharmaceuticals

More information

More Uncertainty: What s The Difference Between a Claim and a Theory?

More Uncertainty: What s The Difference Between a Claim and a Theory? The AIPLA Antitrust News A Publication of the AIPLA Committee on Antitrust Law October 2010 More Uncertainty: What s The Difference By Steven R. Trybus and Sara Tonnies Horton 1 The United States Court

More information

The Appellate Mandate: What It Is and Why It Matters By Jennifer L. Swize

The Appellate Mandate: What It Is and Why It Matters By Jennifer L. Swize ARTICLES The Appellate Mandate: What It Is and Why It Matters By Jennifer L. Swize Just the other day, a trial team handling post-appeal matters on remand wanted to know the significance of the mandate

More information

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA ) FEDERAL TRADE COMMISSION ) 600 Pennsylvania Avenue, N.W. ) Washington, D.C. 20580 ) ) Plaintiff, ) v. ) Civil Action No. 2:08-cv-2141-MSG

More information

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF IDAHO

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF IDAHO IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF IDAHO In re: ALAN GREENWAY, Bankruptcy Case No. 04-04100 dba Greenway Seed Co., Debtor. MEMORANDUM OF DECISION Appearances: D. Blair Clark, RINGERT,

More information

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE REMY INC., UNIT PARTS COMPANY, and WORLDWIDE AUTOMOTIVE, LLC, IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE Plaintiffs, v. C. A. No. 06-785-GMS/MPT CIF LICENSING, LLC D/B/A GE LICENSING,

More information

Case4:12-cv-01971-CW Document815 Filed03/09/15 Page1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA

Case4:12-cv-01971-CW Document815 Filed03/09/15 Page1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA Case:-cv-0-CW Document Filed0/0/ Page of IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA DIGITAL REG OF TEXAS, LLC Plaintiff, v. ADOBE SYSTEMS, INC., et al., Defendants. / No.

More information

Product Lifecycle Management Through Patents

Product Lifecycle Management Through Patents Product Lifecycle Management Through Patents Strategic planning is not just for bit pharma anymore. Specialty pharma, drug delivery, biotech and even generic companies can all greatly benefit from careful

More information

I N S I D E T H E M I N D S

I N S I D E T H E M I N D S I N S I D E T H E M I N D S Food and Drug Law Settlements and Negotiations Leading Lawyers on Complying with Federal Regulations, Negotiating Contracts with Manufacturers and Suppliers, and Defending Clients

More information

Case 1:12-cv-02429-ADS-AKT Document 88-1 Filed 12/16/13 Page 56 of 64 PageID #: 1018 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

Case 1:12-cv-02429-ADS-AKT Document 88-1 Filed 12/16/13 Page 56 of 64 PageID #: 1018 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK Case 1:12-cv-02429-ADS-AKT Document 88-1 Filed 12/16/13 Page 56 of 64 PageID #: 1018 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK IN RE: SINUS BUSTER PRODUCTS CONSUMER LITIGATION Civil Action

More information

Chapter 307. (Senate Bill 585) Commercial Law Patent Infringement Assertions Made in Bad Faith

Chapter 307. (Senate Bill 585) Commercial Law Patent Infringement Assertions Made in Bad Faith Chapter 307 (Senate Bill 585) AN ACT concerning Commercial Law Patent Infringement Assertions Made in Bad Faith FOR the purpose of prohibiting a person from making certain assertions of patent infringement

More information

Are Questions Of Fact Being Overlooked In Software Cases?

Are Questions Of Fact Being Overlooked In Software Cases? Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Are Questions Of Fact Being Overlooked In Software

More information

: : : : : : : : A federal court authorized this notice. This is not a solicitation from a lawyer.

: : : : : : : : A federal court authorized this notice. This is not a solicitation from a lawyer. UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY ----------------------------------------------------------x IN RE SAMSUNG DLP TELEVISION CLASS ACTION LITIGATION This Document Relates to ALL ACTIONS

More information

T.C. Memo. 2015-26 UNITED STATES TAX COURT. RICHARD E. SNYDER AND MARION B. SNYDER, Petitioners v. COMMISSIONER OF INTERNAL REVENUE, Respondent

T.C. Memo. 2015-26 UNITED STATES TAX COURT. RICHARD E. SNYDER AND MARION B. SNYDER, Petitioners v. COMMISSIONER OF INTERNAL REVENUE, Respondent T.C. Memo. 2015-26 UNITED STATES TAX COURT RICHARD E. SNYDER AND MARION B. SNYDER, Petitioners v. COMMISSIONER OF INTERNAL REVENUE, Respondent RICHARD E. SNYDER AND MARION SNYDER, Petitioners v. COMMISSIONER

More information

Patent Reissue. Frequently Asked Questions

Patent Reissue. Frequently Asked Questions Patent Reissue Frequently Asked Questions Patent Reissue Frequently Asked Questions 1 Table of Contents 1. WHAT IS A REISSUE PATENT APPLICATION?...2 2. WHAT TYPES OF SITUATIONS CALL FOR A REISSUED PATENT?...2

More information

Pharmaceutical royalties: a new securitisation frontier Malcolm S Dorris Dechert LLP. Dechert LLP 2007

Pharmaceutical royalties: a new securitisation frontier Malcolm S Dorris Dechert LLP. Dechert LLP 2007 10 Pharmaceutical royalties: a new securitisation frontier Malcolm S Dorris 2007 Securitisation techniques have been increasingly used in less traditional financings involving a wide variety of asset classes.

More information

Federal Jurisdiction in a Lemon Law World

Federal Jurisdiction in a Lemon Law World Federal Jurisdiction in a Lemon Law World Theodore C. Flowers, Esquire Segal McCambridge Singer & Mahoney, Ltd. United Plaza 30 S. 17 th Street, Suite 1700 Philadelphia, PA 19103 (215) 972-8015 tflowers@smsm.com

More information

Pharmaceutical development is an expensive, time

Pharmaceutical development is an expensive, time Exclusivity Strategies in the United States and European Union by Carolyne Hathaway, John Manthei and Cassie Scherer Pharmaceutical development is an expensive, time consuming and uncertain process that

More information

The 505(b)(2) Drug Development Pathway:

The 505(b)(2) Drug Development Pathway: The 505(b)(2) Drug Development Pathway: When and How to Take Advantage of a Unique American Regulatory Pathway By Mukesh Kumar, PhD, RAC and Hemant Jethwani, MS The 505(b)(2) regulation offers a less expensive

More information

THE JOHN MARSHALL LAW SCHOOL CENTER FOR INTELLECTUAL PROPERTY LAW. 53 rd ANNIVERSARY CONFERENCE ON DEVELOPMENTS IN INTELLECTUAL PROPERTY LAW

THE JOHN MARSHALL LAW SCHOOL CENTER FOR INTELLECTUAL PROPERTY LAW. 53 rd ANNIVERSARY CONFERENCE ON DEVELOPMENTS IN INTELLECTUAL PROPERTY LAW THE JOHN MARSHALL LAW SCHOOL CENTER FOR INTELLECTUAL PROPERTY LAW 53 rd ANNIVERSARY CONFERENCE ON DEVELOPMENTS IN INTELLECTUAL PROPERTY LAW Strategies Regarding Patent Exhaustion After Quanta Timothy C.

More information

2:09-cv-14271-LPZ-PJK Doc # 13 Filed 06/24/10 Pg 1 of 6 Pg ID 53 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

2:09-cv-14271-LPZ-PJK Doc # 13 Filed 06/24/10 Pg 1 of 6 Pg ID 53 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION 2:09-cv-14271-LPZ-PJK Doc # 13 Filed 06/24/10 Pg 1 of 6 Pg ID 53 UNITED STATES OF AMERICA, UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION v. Plaintiff, CASE NO. 09-14271 HON.

More information

United States District Court Central District of California Western Division

United States District Court Central District of California Western Division Case :-cv-0-tjh-jc Document Filed 0// Page of Page ID #:0 0 NEWEGG INC., v. United States District Court Central District of California Western Division Plaintiff, EZRA SUTTON, P.A., et al., Defendants.

More information

Case 2:07-cv-10945-SFC-MKM Document 132 Filed 05/27/2008 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

Case 2:07-cv-10945-SFC-MKM Document 132 Filed 05/27/2008 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION Case 2:07-cv-10945-SFC-MKM Document 132 Filed 05/27/2008 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION DURA GLOBAL, TECHNOLOGIES, INC., et al., Plaintiffs, CIVIL

More information

Case 3:15-cv-08128-MLC-LHG Document 1 Filed 11/17/15 Page 1 of 7 PageID: 1

Case 3:15-cv-08128-MLC-LHG Document 1 Filed 11/17/15 Page 1 of 7 PageID: 1 Case 315-cv-08128-MLC-LHG Document 1 Filed 11/17/15 Page 1 of 7 PageID 1 William L. Mentlik Roy H. Wepner Stephen F. Roth Aaron S. Eckenthal LERNER, DAVID, LITTENBERG, KRUMHOLZ & MENTLIK, LLP 600 South

More information

FEDERAL CIRCUIT HOLDS THAT HEIGHTENED PLEADING REQUIREMENTS APPLY TO FALSE MARKING ACTIONS

FEDERAL CIRCUIT HOLDS THAT HEIGHTENED PLEADING REQUIREMENTS APPLY TO FALSE MARKING ACTIONS CLIENT MEMORANDUM FEDERAL CIRCUIT HOLDS THAT HEIGHTENED PLEADING REQUIREMENTS APPLY TO FALSE MARKING ACTIONS In a decision that will likely reduce the number of false marking cases, the Federal Circuit

More information

Case 1:11-cv-04545-AKH Document 1 Filed 07/01/11 Page 1 of 8 SPRINT UNITED MANAGEMENT COMPANY, Plaintiff, Defendant.

Case 1:11-cv-04545-AKH Document 1 Filed 07/01/11 Page 1 of 8 SPRINT UNITED MANAGEMENT COMPANY, Plaintiff, Defendant. Case 1:11-cv-04545-AKH Document 1 Filed 07/01/11 Page 1 of 8 Marshall Bei] Kristina M. Allen McGIAREWOODS LLP 1345 Avenue of the Americas New York, New York 10105-0106 (212) 548-2100 Attorneys for Plainti

More information

In the United States Court of Federal Claims

In the United States Court of Federal Claims In the United States Court of Federal Claims Nos. 12-852C, 12-853C, 12-862C, 12-864C, & 12-869C (Filed: September 29, 2015) CMS CONTRACT MANAGEMENT SERVICES; THE HOUSING AUTHORITY OF THE CITY OF BREMERTON;

More information

Case 6:12-cv-00855-RWS Document 460-6 Filed 03/04/16 Page 1 of 14 PageID #: 33934. Exhibit G

Case 6:12-cv-00855-RWS Document 460-6 Filed 03/04/16 Page 1 of 14 PageID #: 33934. Exhibit G Case 6:12-cv-00855-RWS Document 460-6 Filed 03/04/16 Page 1 of 14 PageID #: 33934 Exhibit G Case 6:12-cv-00855-RWS Document 460-6 Filed 03/04/16 Page 2 of 14 PageID #: 33935 Paper No. 7 UNITED STATES PATENT

More information

THE STATE OF NEW HAMPSHIRE BEFORE THE PUBLIC UTILITIES COMMISSION

THE STATE OF NEW HAMPSHIRE BEFORE THE PUBLIC UTILITIES COMMISSION THE STATE OF NEW HAMPSHIRE BEFORE THE PUBLIC UTILITIES COMMISSION Application of Laws of 2012, Chapter 177 (Senate Bill 48 to VoIP and IP-Enabled Services Docket No. DT 12-308 BRIEF OF AT&T CORP. AND VERIZON

More information

UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES

UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES Ex parte TATSUO NAKAJIMA, ARITO MATSUI, TAKASHI NISHIMOTO, GO ITOHYA, HAJIME ASAI, and TSUNEO TAKANO Appeal

More information

FEE SHIFTING IN PATENT LITIGATION

FEE SHIFTING IN PATENT LITIGATION FEE SHIFTING IN PATENT LITIGATION Sughrue Mion, PLLC Abraham J. Rosner May 2014 I. BACKGROUND In the U.S., each party to litigation ordinarily pays its own attorney fees regardless of the outcome (called

More information

Canada s Patented Medicines (Notice of Compliance) Regulations: Removing Inefficiencies to Encourage Generic Competition

Canada s Patented Medicines (Notice of Compliance) Regulations: Removing Inefficiencies to Encourage Generic Competition Canada s Patented Medicines (Notice of Compliance) Regulations: Removing Inefficiencies to Encourage Generic Competition by Suzanne Marie Porter A thesis submitted in conformity with the requirements for

More information

Best Corporate Practices in Patent Litigation Defense and Offense

Best Corporate Practices in Patent Litigation Defense and Offense Best Corporate Practices in Patent Litigation Defense and Offense Ending Defensive Litigation Quickly and Cheaply and Maximizing Patent Value Joseph J. Berghammer Binal J. Patel MARCH 2015 Joe Berghammer

More information

BEFORE THE FEDERAL MARITIME COMMISSION

BEFORE THE FEDERAL MARITIME COMMISSION BEFORE THE FEDERAL MARITIME COMMISSION COMBUSTION STORE LIMITED, Complainant, V Docket No. 15-02 UNIGROUP WORLDWIDE, INC., Respondent. OFFER OF JUDGMENT COMES NOW, Respondent UNIGROUP WORLDWIDE, inc. and,

More information

CONTENT LICENSE & PHOTOGRAPER REPRENTATION AGREEMENT

CONTENT LICENSE & PHOTOGRAPER REPRENTATION AGREEMENT CONTENT LICENSE & PHOTOGRAPER REPRENTATION AGREEMENT This is a fairly lengthy document, and it contains many important provisions that affect your rights and obligations. By accepting this agreement, you

More information

Dear Lead Judge Mitchell:

Dear Lead Judge Mitchell: VIA EMAIL: trialrules2015@uspto.gov Hon. Susan Mitchell Lead Judge, Patent Trial Proposed Rules Mail Stop Patent Board Director of the United States Patent and Trademark Office P.O. Box 1450 Alexandria,

More information

RECENT PATENT LAW CASES IN THE UNITED STATES: FESTO S EFFECT ON PATENT ACQUISITION PRACTICES. Randall R. Rader

RECENT PATENT LAW CASES IN THE UNITED STATES: FESTO S EFFECT ON PATENT ACQUISITION PRACTICES. Randall R. Rader RECENT PATENT LAW CASES IN THE UNITED STATES: FESTO S EFFECT ON PATENT ACQUISITION PRACTICES Randall R. Rader Circuit Judge, United States Court of Appeals for the Federal Circuit Adjunct Professor, George

More information

Beware The New Patent Trolls: False Patent Marking Claims after Forest Group v. Bon Tool. Professor Thomas Cotter (Univ.

Beware The New Patent Trolls: False Patent Marking Claims after Forest Group v. Bon Tool. Professor Thomas Cotter (Univ. Beware The New Patent Trolls: False Patent Marking Claims after Forest Group v. Bon Tool Professor Thomas Cotter (Univ. of MN Law School) Eran Kahana (DataCard Corp.) Michael Lafeber (Briggs & Morgan)

More information

Securities Litigation

Securities Litigation Securities Litigation Alert July 2009 Eleventh Circuit Affirms Bar Order, in Connection with Partial Settlement of Class Action, Extinguishing Non-Settling Former CEO Defendant s Contractual Rights to

More information

The KSR Standard for Obviousness: A Pendulum Shift to 20/20 Hindsight? Michael O. Warnecke, Partner Perkins Coie

The KSR Standard for Obviousness: A Pendulum Shift to 20/20 Hindsight? Michael O. Warnecke, Partner Perkins Coie The KSR Standard for Obviousness: A Pendulum Shift to 20/20 Hindsight? Michael O. Warnecke, Partner Perkins Coie KSR International Co. v. Teleflex, Inc. April 30, 2007 U.S. Supreme Court s unanimous decision

More information

Case: 1:13-cv-00260 Document #: 55 Filed: 08/16/13 Page 1 of 10 PageID #:

Case: 1:13-cv-00260 Document #: 55 Filed: 08/16/13 Page 1 of 10 PageID #:<pageid> Case: 1:13-cv-00260 Document #: 55 Filed: 08/16/13 Page 1 of 10 PageID #: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION DENTAL USA, INC. Plaintiff, v. No. 13 CV 260

More information

F I L E D August 5, 2013

F I L E D August 5, 2013 Case: 12-60648 Document: 00512331827 Page: 1 Date Filed: 08/05/2013 IN THE UNITED STATES COURT OF APPEALS United States Court of Appeals FOR THE FIFTH CIRCUIT Fifth Circuit F I L E D August 5, 2013 Lyle

More information

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE. Chapter 11

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE. Chapter 11 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: TACTICAL INTERMEDIATE HOLDINGS, INC., et al., 1 Debtors. Chapter 11 Case No. 14-11659 (KG) (Jointly Administered) Objections Due:

More information

Case 5:06-cv-00503-XR Document 20 Filed 09/28/06 Page 1 of 7 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION

Case 5:06-cv-00503-XR Document 20 Filed 09/28/06 Page 1 of 7 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION Case 5:06-cv-00503-XR Document 20 Filed 09/28/06 Page 1 of 7 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION UNITED STATES OF AMERICA, VS. Plaintiff, HENRY D. GOLTZ, EVANGELINA

More information

Hastings Science & Technology Law Journal

Hastings Science & Technology Law Journal William J. Newsom: Reverse Payment Settlement Problem Hastings Science & Technology Law Journal Exceeding the Scope of the Patent: Solving the Reverse Payment Settlement Problem Through Antitrust Enforcement

More information

Following is a restatement of the primary duties of the six paralegals you describe:

Following is a restatement of the primary duties of the six paralegals you describe: December 16, 2005 FLSA2005-54 Dear Name* : This is in response to your request for a formal opinion on the application of Section 13(a)(1) of the Fair Labor Standards Act (FLSA) to several paralegals employed

More information

Defensive Strategies in False Marking Suits After Stauffer and Pequignot

Defensive Strategies in False Marking Suits After Stauffer and Pequignot Defensive Strategies in False Marking Suits After Stauffer and Pequignot Contributed by Angie M. Hankins, Stroock & Stroock & Lavan LLP Many companies inadvertently mark their products with expired patents.

More information

F I L E D July 17, 2013

F I L E D July 17, 2013 Case: 12-11255 Document: 00512311028 Page: 1 Date Filed: 07/17/2013 IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT No. 12-11255 Summary Calendar COMPANION PROPERTY AND CASUALTY INSURANCE COMPANY,

More information

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT. vs. : No. 3:04CV817(WWE) Ruling on Defendant s Motion to Dismiss [Doc. # 10]

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT. vs. : No. 3:04CV817(WWE) Ruling on Defendant s Motion to Dismiss [Doc. # 10] UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT AETNA LIFE & CASUALTY, : Plaintiff, : vs. : No. 3:04CV817(WWE) WILLIAM L. OWEN, : Defendant. : / Ruling on Defendant s Motion to Dismiss [Doc. # 10]

More information

DOL Whistleblower Rule Will Have Far-Reaching Effects

DOL Whistleblower Rule Will Have Far-Reaching Effects Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com DOL Whistleblower Rule Will Have Far-Reaching Effects

More information

DEVELOPMENTS IN THE TRANSFER OF PATENT RIGHTS

DEVELOPMENTS IN THE TRANSFER OF PATENT RIGHTS PROTECTING PATENTS AND TRADEMARKS THE U.S. MODEL DEVELOPMENTS IN THE TRANSFER OF PATENT RIGHTS Paolo M. Trevisan Patent Attorney Office of Policy and External Affairs United States Patent and Trademark

More information

JULY/AUGUST 2013 DEVOTED TO INT ELLECTUAL P ROPERTY LIT IGATION & ENFORCEMENT. Edited by the Law Firm of Grimes & Battersby.

JULY/AUGUST 2013 DEVOTED TO INT ELLECTUAL P ROPERTY LIT IGATION & ENFORCEMENT. Edited by the Law Firm of Grimes & Battersby. JULY/AUGUST 2013 VOLUME 19 NUMBER 4 DEVOTED TO INT ELLECTUAL P ROPERTY LIT IGATION & ENFORCEMENT Edited by the Law Firm of Grimes & Battersby Litigator Effective Selection and Retention of Testifying Experts

More information

ITC Section 337 Investigations: Patent Infringement Claims

ITC Section 337 Investigations: Patent Infringement Claims ITC Section 337 Investigations: Patent Infringement Claims H. Mark Lyon, Gibson, Dunn & Crutcher LLP and Sarah E. Piepmeier, Kirkland & Ellis LLP A Practice Note describing Section 337 investigations involving

More information

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA ORLANDO DIVISION

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA ORLANDO DIVISION ORLANDO COMMUNICATIONS LLC, UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA ORLANDO DIVISION Plaintiff, v. Case No: 6:14-cv-1022-Orl-22KRS SPRINT SPECTRUM, L.P. and SPRINT CORPORATION, Defendants.

More information

CASE 0:05-cv-01578-JMR-JJG Document 59 Filed 09/18/06 Page 1 of 7 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA 05-CV-1578(JMR/JJG)

CASE 0:05-cv-01578-JMR-JJG Document 59 Filed 09/18/06 Page 1 of 7 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA 05-CV-1578(JMR/JJG) CASE 0:05-cv-01578-JMR-JJG Document 59 Filed 09/18/06 Page 1 of 7 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA 05-CV-1578(JMR/JJG) State of Minnesota ) ) v. ) ORDER ) Robert B. Beale, Rebecca S.

More information

NOTICE OF PROPOSED CLASS ACTION SETTLEMENT

NOTICE OF PROPOSED CLASS ACTION SETTLEMENT NOTICE OF PROPOSED CLASS ACTION SETTLEMENT Hoover v. Hi Tech Pharmacal Co., Inc. Case No. EDCV 13 00097 JGB (OPx) If you purchased a product manufactured by Hi Tech Pharmacal Co., Inc., called Nasal Ease

More information

Henkel Corp v. Hartford Accident

Henkel Corp v. Hartford Accident 2008 Decisions Opinions of the United States Court of Appeals for the Third Circuit 3-27-2008 Henkel Corp v. Hartford Accident Precedential or Non-Precedential: Non-Precedential Docket No. 06-4856 Follow

More information

SUBSTITUTE SENATE BILL 5059. State of Washington 64th Legislature 2015 Regular Session

SUBSTITUTE SENATE BILL 5059. State of Washington 64th Legislature 2015 Regular Session S-1.1 SUBSTITUTE SENATE BILL 0 State of Washington th Legislature 01 Regular Session By Senate Law & Justice (originally sponsored by Senators Frockt, Fain, Pedersen, and Chase; by request of Attorney

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit JULIO G. PIMENTEL, Petitioner, v. MERIT SYSTEMS PROTECTION BOARD, Respondent. Julio G. Pimentel, of Rosharon,

More information

Richmond Journal of Law & Technology Volume XVIII, Issue 4. By Scott Bergeson*

Richmond Journal of Law & Technology Volume XVIII, Issue 4. By Scott Bergeson* A VACCINE APPROACH TO THE REVERSE PAYMENT ILLNESS By Scott Bergeson* Cite as: Scott Bergeson, A Vaccine Approach to the Reverse Payment Illness, XVIII RICH. J.L. & TECH. 14, http://jolt.richmond.edu/v18i4/article14.pdf

More information

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF WISCONSIN GREEN BAY DIVISION

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF WISCONSIN GREEN BAY DIVISION IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF WISCONSIN GREEN BAY DIVISION YANGAROO INC., Plaintiff, Case No. 09-C-0462 -v- DESTINY MEDIA TECHNOLOGIES INC., DESTINY SOFTWARE PRODUCTIONS

More information

Case 2:14-cv-01214-DGC Document 38 Filed 08/25/14 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ARIZONA

Case 2:14-cv-01214-DGC Document 38 Filed 08/25/14 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ARIZONA Case :-cv-0-dgc Document Filed 0// Page of 0 WO Wintrode Enterprises Incorporated, v. PSTL LLC, et al., IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ARIZONA Plaintiff, Defendants. No. CV--0-PHX-DGC

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit IN RE MARK T. DINSMORE AND DAVID J. CARUSO 2013-1637 Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Serial

More information

ALI-ABA Topical Courses False Patent Marking: Crafting Your Defense As the Law Evolves October 27, 2010 Telephone Seminar/Audio Webcast

ALI-ABA Topical Courses False Patent Marking: Crafting Your Defense As the Law Evolves October 27, 2010 Telephone Seminar/Audio Webcast 1 ALI-ABA Topical Courses False Patent Marking: Crafting Your Defense As the Law Evolves October 27, 2010 Telephone Seminar/Audio Webcast Select 2010 N.D. Illinois False Patent Marking Opinions and Orders

More information

Case 2:13-cv-01887-ES-JAD Document 282-1 Filed 12/09/15 Page 1 of 18 PageID: 4861 THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

Case 2:13-cv-01887-ES-JAD Document 282-1 Filed 12/09/15 Page 1 of 18 PageID: 4861 THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY Case 2:13-cv-01887-ES-JAD Document 282-1 Filed 12/09/15 Page 1 of 18 PageID: 4861 THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY Federal Trade Commission, Plaintiff, v. Wyndham Worldwide

More information

You've Been Served: A Guide For Accountants

You've Been Served: A Guide For Accountants Portfolio Media. Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 customerservice@portfoliomedia.com You've Been Served: A Guide For Accountants

More information

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY DEFENDANT S ANSWER

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY DEFENDANT S ANSWER Case 1:14-cv-05919-JEI-KMW Document 19 Filed 02/13/15 Page 1 of 11 PageID: 84 Frank L. Corrado, Esquire Attorney ID No. 022221983 BARRY, CORRADO & GRASSI, PC 2700 Pacific Avenue Wildwood, NJ 08260 (609)

More information

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE RELUME CORPORATION TRUST, and DENNY FOY, SHAWN GRADY and MARIE HOCHSTEIN, TRUSTEES, Civil Action No.: Plaintiffs, v. DEMAND FOR JURY TRIAL

More information

J.A.Kemp & Co. London. Munich. Oxford

J.A.Kemp & Co. London. Munich. Oxford J.A.Kemp & Co. London Munich Oxford 1 WIPO/AIPPI Conference on Client Privilege in Intellectual Property Professional Advice Outcomes of litigation and needs arising in relation to client/ip professional

More information

A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act

A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act March 2013 A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act BY STEPHEN H. HARRIS, MELINDA A. GORDON & MARC E. BERNSTEIN INTRODUCTION On February 22, 2013, the United States

More information

The Lead Compound Analysis for Chemical Obviousness: USPTO v. the Courts

The Lead Compound Analysis for Chemical Obviousness: USPTO v. the Courts The Lead Compound Analysis for Chemical Obviousness: USPTO v. the Courts Jeffry M. Nichols & William A. Carroll Ph.D. Brinks Gilson & Lione Over the last several years, the Federal Circuit has imposed

More information